First interim analysis of the German prospective, noninterventional study JAKoMo: First results on the daily clinical routine of ruxolitinib in Myelofibrosis

被引：0
|
作者：
Heinrich, B.
Geer, T. [1 ]
Hochdoerfer, S. [2 ]
Jordan, W. O. [3 ]
Losem, C. [4 ]
Haug, D. [5 ]
Cavanna, D. [5 ]
Fritsche, P. [5 ]
Koschmieder, S. [6 ]
机构：
[1] Diakonie Klinikum Schwabisch Hall, Med Klin 3, Schwabisch Hall, Germany
[2] Onkol Praxis Rehling, Rehling, Germany
[3] Onkol Praxis Lehrte, Lehrte, Germany
[4] TZN Tumorzentrum Niederrhein GmbH, Niederrhein, Germany
[5] Novartis Pharma GmbH, Nurnberg, Germany
[6] Uniklin RWTH Aachen, Fak Med, Klin Onkol Hamatol & SZT, Aachen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P212
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [1] 2016 Interim analysis of the prospective, non-interventional study JAKoMo: new insights into ruxolitinib treatment of myelofibrosis in daily clinical routine
    Geer, T.
    Heinrich, B.
    Jacobasch, L.
    Tesch, H.
    Wehmeyer, J.
    Schlag, R.
    Groeschl, B.
    Markhauser, M.
    Bachhuber, P.
    Koschmieder, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 149 - 149
  • [2] First interim analysis of the German prospective, non-interventional study PaVe: first results on the clinical routine of ruxolitinib in polycythemia vera
    Griesshammer, M.
    von der Heyde, E.
    Weide, R.
    Reichert, D.
    Weniger, J.
    Schlag, R.
    Hutzschenreuter, U.
    Becker, M.
    Just, M.
    Hacker, E.
    Cavanna, D.
    Lengfelder, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 148 - +
  • [3] "Real-world" data on the use of ruxolitinib in myelofibrosis: 2018 interim analysis of the prospective, non-interventional study JAKoMo
    Koschmieder, S.
    Jacobasch, L.
    Schulte, C.
    Geer, T.
    Brudler, O.
    Wehmeyer, J.
    Klausmann, M.
    Groeschl, B.
    Grosser, S.
    Pahl, H. L.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 98 - 99
  • [4] Interim results of the phase IV JAKoMo trial, a prospective, non-interventional study of symptoms and quality of life in myelofibrosis patients receiving ruxolitinib therapy
    Wehrle, J.
    Geer, T.
    Brudler, O.
    Schaefer, E.
    Tesch, H.
    Cavanna, D.
    Bachhuber, P.
    Markhauser, M.
    Koschmieder, S.
    Mesa, R. A.
    Pahl, H. L.
    Oncology Research and Treatment, 2015, 38 : 227 - 228
  • [5] Symptomatic effectiveness of ozanimod in routine clinical care of ulcerative colitis: an interim analysis of the multicentre, prospective, noninterventional COLIBRI study
    Schubert, S.
    Stein, J.
    Efken, P.
    Helwig, U.
    Schulze, J.
    Hellms, T.
    Jorgensen, E.
    Poehler, A. M.
    Scheibner, F.
    Makki, M.
    Zeissig, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1568 - I1569
  • [6] Practicability of the Brief International Cognitive Assessment in MS (BICAMS) in Daily Clinical Routine: First Results of the German Feasibility Study
    Penner, Iris-Katharine
    Filser, Melanie
    Mingers, Daniel
    Lassek, Christoph
    NEUROLOGY, 2016, 86
  • [7] First interim results of PANGAEA 2.0: patients switching to fingolimod from other oral DMTs in daily clinical routine
    Cornelissen, C.
    Kern, R.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 595 - 595
  • [8] Abnormalities detected by the first routine newborn examination - Results of prospective study
    Preut, D
    Reiter, HL
    Klingmuller, V
    Kuhl, G
    MONATSSCHRIFT KINDERHEILKUNDE, 1996, 144 (10) : 1092 - 1097
  • [9] Secondary resection in a general mCRC population with cetuximab-based first-line treatment: Interim analysis of the German noninterventional study ERBITAG
    Overkamp, Friedrich
    Goehler, Thomas
    Reich, Gernot
    Schwerdtfeger, Michael
    Stuebs, Patrick
    Stenzel, Karsten G.
    Neumann, Ulf P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [10] Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI)
    Breccia, Massimo
    Palandri, Francesca
    Martelli, Maurizio
    Mendicino, Francesco
    Malato, Alessandra
    Palumbo, Giuseppe A.
    Sibilla, Silvia
    Di Renzo, Nicola
    Abruzzese, Elisabetta
    Siragusa, Sergio
    Crugnola, Monica
    Selleri, Carmine
    Pane, Fabrizio
    Sportoletti, Paolo
    Martino, Bruno
    Impera, Stefana
    Ricco, Alessandra
    Langella, Maria
    Ditonno, Paolo
    Carli, Giuseppe
    Itri, Federico
    Liberati, Anna Marina
    Urbano, Tiziana
    Tafuri, Agostino
    Polizzi, Vita
    Pastore, Domenico
    Morsia, Erika
    Benevolo, Giulia
    Micucci, Giorgia
    Farina, Gabriella
    Bonifacio, Massimiliano
    Elli, Elena Maria
    Gardellini, Angelo
    De Stefano, Valerio
    Caocci, Giovanni
    Falcone, Antonietta Pia
    Vallisa, Daniele
    Brociner, Marco
    Tiribelli, Mario
    Binotto, Gianni
    Pocali, Barbara
    Cavazzini, Francesco
    Tomassetti, Simona
    Lunghi, Francesca
    Di Ianni, Mauro
    Allegra, Alessandro
    Anaclerio, Barbara
    Mazzotta, Serena
    Orofino, Nicola
    Gherlinzoni, Filippo
    CANCER, 2025, 131 (07)
12345